Julia Wang
Director of Finance/CFO at BEIGENE, LTD.
Net worth: 4 M $ as of 2024-03-30
Julia Wang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BEIGENE, LTD. | Director of Finance/CFO | 2021-06-29 | - |
| Comptroller/Controller/Auditor | 2021-06-29 | 2024-03-18 | |
| Corporate Officer/Principal | 2020-05-31 | 2021-06-29 |
Career history of Julia Wang
Former positions of Julia Wang
| Companies | Position | Start | End |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-12-31 | 2019-12-31 |
| QUEST DIAGNOSTICS INCORPORATED | Corporate Officer/Principal | 2014-12-31 | 2017-12-31 |
Training of Julia Wang
| Shandong Normal University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Statistics
International
| United States | 4 |
| China | 2 |
| Cayman Islands | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| QUEST DIAGNOSTICS INCORPORATED | Health Services |
| BEIGENE, LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Julia Wang
- Experience